Anne-Marie Martin

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne-Marie Martin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 38,513 12 Jun 2025 Direct

Insider Reports Filed by Anne-Marie Martin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:07
CGEM Cullinan Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 27 Jun 2024, 19:00
CGEM Cullinan Oncology, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 17:50
CGEM Cullinan Oncology, Inc. 01 Mar 2022 1 $0 4 Director 02 Mar 2022, 18:05
CGEM Cullinan Oncology, Inc. 01 Mar 2022 0 $0 3 Director 02 Mar 2022, 18:04